Home | AI powered stock trade ideas | Market Signals | Breaking Out | New Green AI Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

AI Powered Stock Trade Ideas
86% AI Stock Prediction Accuracy
Enter Stock Symbol to View AI powered Stock Chart


All Chart Prices as of Previous Day Close

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.

Last Price: 44.73 - Change: -0.12 - Change %: -0.2676
02/23/2024 16:00:00 EST

Integra LifeSciences Holdings (IART)

Industry: Medical Devices

Price Support Resistance

In the past 20 trading days, IART has been trading in a range between $45.20 and $39.50 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

IART is trading below resistance at $45.97, about 3% to the upside. There is support at $43.26 -3% to the downside. If it can break above the resistance, it could have some more upside. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.

Upside / Downside Potential

Integra LifeSciences Holdings (IART) entered a Green zone 10 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $46.89, a potential upside of 4.83% from the recent price of 44.73. Our AI powered stock target predictor currently has a target price of $58.20 a potential move of 30%. The stock is trading 32.64% (potential upside) below its 52 week high of $59.33 and 33.76 % (potential downside) above its 52 week low of $33.44 - based on the recent price.

Company Summary

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.

IART Website


Earnings Preview: Integra LifeSciences (IART) Q4 Earnings Expected to Decline
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Source: Zacks Investment Research
Wed, 21 Feb 2024 11:06:33 -0500
Sentiment: Negative
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET.
Source: GlobeNewsWire
Wed, 07 Feb 2024 09:15:00 -0500
Sentiment: Neutral
Here's Why Investors Should Retain Integra (IART) Stock Now
Investors remain optimistic about Integra (IART) due to the positive outlook for its CSS segment.
Source: Zacks Investment Research
Wed, 10 Jan 2024 08:16:05 -0500
Sentiment: Positive
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P. Morgan Healthcare conference on January 10, 2024 at 1:30pm ET.
Source: GlobeNewsWire
Fri, 05 Jan 2024 16:30:00 -0500
Sentiment: Neutral
Integra (IART) to Advance ENT Division With New Buyout Deal
Integra (IART) will be among the top suppliers of ENT products and technologies following the Acclarent acquisition.
Source: Zacks Investment Research
Thu, 14 Dec 2023 12:48:15 -0500
Sentiment: Neutral
Instituions Institution %: 88.908
Last QTR Institution change: 3492044

Insiders %: 13.804
Insiders Purchases last QTR: 7792
Insiders Sales last QTR: 5610
Insiders Net last QTR: 2182

Analyst Ratings
Target Price: 46.89
Overall Rating: 3.1539
Strong Buys (5): 3
Buys (4): 2
Holds (3): 4
Sells (2): 2
Strong Sells (1): 2

52 Week Hi: 59.33
52 Week Low: 33.44
Beta: 1.176
50 Day MA: 42.728
200 Day MA: 41.4137

Earnings / Revenue Trends
Qtr Earnings Growth YOY: -0.6
Qtr Revenue Growth YOY: -0.007
Forward PE: 13.0378
Trailing PE: 36.6639

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!


Stock Analyzed Each Night


Easily Upload Track Your Stocks


See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.